Prostate News Archive
22-Oct-2006
NCI releases data on prostate cancer and gene link (PharmaBiz)
The National Cancer Institute (NCI), part of the National Institutes of Health, has released new data from the Cancer Genetic Markers of Susceptibility (CGEMS) study on prostate cancer. Top Cancer Physician-Scientist Named New Head of the Prostate Cancer Foundation (U.S. Newswire via Yahoo! News)
One of the nation's leading prostate cancer researchers has been named Chief Executive Officer and president of the prostate Cancer Foundation (PCF), the world's largest philanthropic source of support for prostate cancer research. UWM Chancellor to Have Surgery for Prostate Cancer (RedNova)
By Megan Twohey, Milwaukee Journal Sentinel Oct. 20--Carlos Santiago, chancellor of the University of Wisconsin-Milwaukee, announced Thursday that he will undergo surgery for prostate cancer next week and will be limiting his public appearances for four to six weeks. Control Of Prostate Cancer By Transrectal HIFU In 227 Patients (Medical News Today)
UroToday.com - High-intensity focused ultrasound (HIFU) is a novel treatment for localized prostate cancer. Dr. Poissonnier and associates from Lyon, France report their outcomes in 227 patients treated with HIFU in the epub version of European Urology. HIFU produces ultrasound waves that are generated by a transducer and result in necrosis of prostate tissue. [click link for full article] 7 Keys to Prostate Cancer Management (HealthDay via Yahoo! News)
THURSDAY, Oct. 19 (HealthDay News) -- Early detection and treatment are crucial to defeat prostate cancer, says a Johns Hopkins Health Alerts report that outlines seven key ways to treat prostate cancer and provides advice on how to prevent it. Best option for prostate cancer treatment is individual choice (Agriculture Online)
Allen Lash began with a belief that surgery was his last choice to cure prostate cancer. "When you're diagnosed with prostate cancer, you're dealing with two main issues," he says. "First, your own survival. Second, quality-of-life issues, such as incontinence and sexual function. Dendreon Announces New Data Analyses Presented at Prostate Cancer Foundation Scientific Retreat (PR Newswire via Yahoo! Finance)
Dendreon Corporation today announced that Eric J. Small, M.D., professor of medicine and urology at the University of California, San Francisco presented new exploratory analyses of the Phase 3 Study that further support the results observed with the Company's investigational active cellular immunotherapy PROVENGEŽ in men with advanced androgen- independent prostate cancer. Cay Crow: Check with doctor before mixing drugs for ED, prostate trouble (San Antonio Express News)
Dear Cay: I am a 78-year-old male who lost my 56-year-old wife 15 months ago. Two months after her death, I began to experience prostate problems (slow urination).
Back to Prostate News Archive
